Literature DB >> 32602083

In vivo Characterization of Four 18F-Labeled S1PR1 Tracers for Neuroinflammation.

Hui Liu1, Zonghua Luo1, Jiwei Gu1, Hao Jiang1, Sumit Joshi1, Kooresh I Shoghi1, Yun Zhou1, Robert J Gropler1, Tammie L S Benzinger1, Zhude Tu2.   

Abstract

PURPOSE: The sphingosine-1-phosphate receptor 1 (S1PR1) is an important biomarker for imaging inflammation in the central nervous system (CNS). Herein, we report our recent evaluation of four 18F-labeled S1PR1 tracers (18F-TZ43113, 18F-TZ35104, 18F-TZ4877, and 18F-TZ4881) in a rat model of multiple sclerosis (MS). PROCEDURES: MicroPET studies of each tracer's uptake and kinetics were performed in an experimental autoimmune encephalomyelitis (EAE) rat model of MS to quantify upregulated S1PR1 expression in the lumbar spinal cord of EAE rats. Western blot analysis was conducted to confirm the differences in the expression of S1PR1 protein level between EAE and sham rats. Radiometabolite analysis was performed for the most promising candidate in rats.
RESULTS: All four S1PR1 tracers detected increased S1PR1 levels in response to neuroinflammation in the lumbar spinal cord of EAE rats, which was supported by western blot results. The ranked order of tracer uptake in rat spinal cord was 18F-TZ4877 > 18F-TZ4881 > 18F-TZ35104 > 18F-TZ43113. 18F-TZ4877 had the highest uptake of the four tracers and showed good kinetic modeling fits in rat spinal cord using an image-based method of arterial blood input function. Radiometabolite analysis of 18F-TZ4877 showed good in vivo stability with no major radiometabolite accumulation in the rat brain.
CONCLUSION: Among these four new PET tracers, 18F-TZ4877 showed the most favorable profile for assessing S1PR1 expression in the EAE rat model of MS. Further characterization of these radiotracers in other models of neuroinflammation is warranted to identify a promising 18F-labeled tracer for imaging S1PR1 in vivo.

Entities:  

Keywords:  Fluorine-18; Neuroinflammation; PET radioligands; Sphingosine-1-phosphate receptor 1

Year:  2020        PMID: 32602083      PMCID: PMC7679043          DOI: 10.1007/s11307-020-01514-8

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  1 in total

1.  PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements.

Authors:  Sami S Zoghbi; H Umesha Shetty; Masanori Ichise; Masahiro Fujita; Masao Imaizumi; Jeih-San Liow; Jay Shah; John L Musachio; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2006-03       Impact factor: 10.057

  1 in total
  4 in total

1.  Radiosynthesis and evaluation of a fluorine-18 radiotracer [18F]FS1P1 for imaging sphingosine-1-phosphate receptor 1.

Authors:  Lin Qiu; Hao Jiang; Yanbo Yu; Jiwei Gu; Jinzhi Wang; Haiyang Zhao; Tianyu Huang; Robert J Gropler; Robyn S Klein; Joel S Perlmutter; Zhude Tu
Journal:  Org Biomol Chem       Date:  2022-02-02       Impact factor: 3.876

Review 2.  Does Siponimod Exert Direct Effects in the Central Nervous System?

Authors:  Markus Kipp
Journal:  Cells       Date:  2020-07-24       Impact factor: 6.600

3.  PET Study of Sphingosine-1-phosphate Receptor 1 Expression in Response to S. aureus Infection.

Authors:  Hao Jiang; Jiwei Gu; Haiyang Zhao; Sumit Joshi; Joel S Perlmutter; Robert J Gropler; Robyn S Klein; Tammie L S Benzinger; Zhude Tu
Journal:  Mol Imaging       Date:  2021-10-04       Impact factor: 3.250

4.  Differential Sphingosine-1-Phosphate Receptor-1 Protein Expression in the Dorsolateral Prefrontal Cortex Between Schizophrenia Type 1 and Type 2.

Authors:  Ganesh B Chand; Hao Jiang; J Philip Miller; C Harker Rhodes; Zhude Tu; Dean Foster Wong
Journal:  Front Psychiatry       Date:  2022-03-08       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.